196 related articles for article (PubMed ID: 22539003)
1. A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells.
Tate CM; Pallini R; Ricci-Vitiani L; Dowless M; Shiyanova T; D'Alessandris GQ; Morgante L; Giannetti S; Larocca LM; di Martino S; Rowlinson SW; De Maria R; Stancato L
Cell Death Differ; 2012 Oct; 19(10):1644-54. PubMed ID: 22539003
[TBL] [Abstract][Full Text] [Related]
2. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
[TBL] [Abstract][Full Text] [Related]
3. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
Nana AW; Yang PM; Lin HY
Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
[TBL] [Abstract][Full Text] [Related]
4. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.
Veschi V; Mangiapane LR; Nicotra A; Di Franco S; Scavo E; Apuzzo T; Sardina DS; Fiori M; Benfante A; Colorito ML; Cocorullo G; Giuliante F; Cipolla C; Pistone G; Bongiorno MR; Rizzo A; Tate CM; Wu X; Rowlinson S; Stancato LF; Todaro M; De Maria R; Stassi G
Oncogene; 2020 Jan; 39(5):987-1003. PubMed ID: 31591478
[TBL] [Abstract][Full Text] [Related]
5. Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma.
González-Gómez P; Crecente-Campo J; Zahonero C; de la Fuente M; Hernández-Laín A; Mira H; Sánchez-Gómez P; Garcia-Fuentes M
Oncotarget; 2015 May; 6(13):10950-63. PubMed ID: 25860932
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.
Stockhausen MT; Kristoffersen K; Stobbe L; Poulsen HS
Cancer Biol Ther; 2014 Feb; 15(2):216-24. PubMed ID: 24525857
[TBL] [Abstract][Full Text] [Related]
7. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
[TBL] [Abstract][Full Text] [Related]
9. BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma.
Porcù E; Maule F; Boso D; Rampazzo E; Barbieri V; Zuccolotto G; Rosato A; Frasson C; Viola G; Della Puppa A; Basso G; Persano L
Cell Death Differ; 2018 Nov; 25(10):1808-1822. PubMed ID: 29977042
[TBL] [Abstract][Full Text] [Related]
10. GSK‑3 inhibitor CHIR99021 enriches glioma stem‑like cells.
Yang Y; Wang QQ; Bozinov O; Xu RX; Sun YL; Wang SS
Oncol Rep; 2020 May; 43(5):1479-1490. PubMed ID: 32323804
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.
Piccirillo SG; Reynolds BA; Zanetti N; Lamorte G; Binda E; Broggi G; Brem H; Olivi A; Dimeco F; Vescovi AL
Nature; 2006 Dec; 444(7120):761-5. PubMed ID: 17151667
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
[TBL] [Abstract][Full Text] [Related]
14. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
Carra E; Barbieri F; Marubbi D; Pattarozzi A; Favoni RE; Florio T; Daga A
Cell Cycle; 2013 Feb; 12(3):491-500. PubMed ID: 23324350
[TBL] [Abstract][Full Text] [Related]
16. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
[TBL] [Abstract][Full Text] [Related]
17. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells.
Sherry MM; Reeves A; Wu JK; Cochran BH
Stem Cells; 2009 Oct; 27(10):2383-92. PubMed ID: 19658181
[TBL] [Abstract][Full Text] [Related]
18. The effects of type I interferon on glioblastoma cancer stem cells.
Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival.
Duggal R; Geissinger U; Zhang Q; Aguilar J; Chen NG; Binda E; Vescovi AL; Szalay AA
J Transl Med; 2013 Jun; 11():155. PubMed ID: 23800258
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
